L'espansione osservata in questo mercato può essere attribuita a diversi fattori, tra cui il numero sostanziale di approvazioni concesse per i dispositivi di chiusura vascolare, l'incidenza prevalente di malattie cardiovascolari , la crescente prevalenza di obesità, la crescente enfasi delle entità di mercato sui dispositivi di chiusura vascolare di grande calibro, la crescente demografia geriatrica, il favorevole panorama di rimborso per le procedure di radiologia interventistica e l'attenzione accresciuta sulla gestione efficace della perdita di sangue durante gli interventi chirurgici. Inoltre, i mercati emergenti presentano prospettive di crescita redditizie per i partecipanti al mercato, insieme alla proliferazione di ospedali e centri chirurgici, che collettivamente offrono solide opportunità di crescita.
Il mercato dei dispositivi di chiusura vascolare (VCD) comprende una serie di dispositivi medici progettati per ottenere l'emostasi in seguito a procedure vascolari minimamente invasive, in particolare cateterizzazione cardiaca e interventi vascolari periferici. Questi dispositivi sono fondamentali per sigillare i siti di puntura all'interno di arterie o vene, mitigando così il rischio di complicazioni emorragiche post-procedurali. I VCD presentano vantaggi distinti rispetto alle tecniche di compressione manuale convenzionali, tra cui emostasi accelerata, tempi di deambulazione ridotti, minore disagio per il paziente e ricoveri ospedalieri abbreviati. Tipi degni di nota di dispositivi di chiusura vascolare comprendono tappi di collagene, dispositivi mediati da suture, sistemi basati su clip e patch emostatiche, ciascuno personalizzato con meccanismi di azione specifici per soddisfare diversi siti anatomici e requisiti procedurali.
| ATTRIBUTO | DETTAGLI |
| Periodo di studio | 2020-2029 |
| Anno base | 2021 |
| Anno stimato | 2022 |
| Anno previsto | 2022-2029 |
| Periodo storico | 2018-2020 |
| Unità | Valore (miliardi di USD) |
| Segmentazione | Per tipo, per accesso, per procedura |
| Per tipo |
|
| Per accesso |
|
| Per Procedura |
|
| Per regione |
|
Il panorama normativo globale che disciplina i dispositivi di chiusura vascolare è caratterizzato da un quadro multiforme che comprende standard, linee guida e regolamenti promulgati dalle autorità di regolamentazione in diverse nazioni e regioni. Enti come la Food and Drug Administration (FDA) degli Stati Uniti, l'Agenzia europea per i medicinali (EMA) e la Japan Pharmaceuticals and Medical Devices Agency (PMDA) delineano i requisiti relativi alla sicurezza, all'efficacia e alla qualità dei VCD tramite processi di approvazione pre-commercializzazione, meccanismi di sorveglianza post-commercializzazione e valutazioni di routine.
In terms of value, oligomers account for a sizable portion of the composition type.
The sector of passive approximators led the Vascular closure devices market.
The vascular closure devices market is divided into three types: passive approximators, active approximators, and external hemostatic devices. The market for vascular closure devices is dominated by passive approximators. The growing number of vascular closure device approvals, as well as the numerous benefits connected with these devices, such as ease of use and a lower complication rate in patients, can be attributable to the substantial proportion of this market.
During the projected period, the interventional radiology segment is expected to increase the most.The vascular closure devices market is divided into two segments based on procedure: interventional cardiology procedures and interventional radiology/vascular surgery. The interventional cardiology segment accounts for the lion's share of the vascular closure devices market. Because of developments in angioplasty and cardiac stenting, as well as the increased frequency of cardiac illnesses internationally, the major share is attributable to the diagnosis and treatment of multiple cardiovascular disorders.
The primary customers of vascular closure devices are acute care centers, clinics, and hospitals. Acute care facilities are the market's most important end consumers. There has also been an increase in the number of cases of cardiovascular disorders that require immediate treatment, which has raised awareness of the use of VCDs in acute care treatment. Furthermore, the use of imaging technologies, such as echocardiography, in acute treatment for CVD drives market expansion.
In addition to disease prevalence, technological advancements in vascular closure devices will drive industry revenue in the next few years. The advancement of vascular closure devices enabled minimal intrusions, great patient outcomes, early ambulation, a short hospital stay, and patient comfort throughout treatments. This has resulted in excellent product acceptance as compared to manual compression procedures previously employed in the industry. Furthermore, product approvals, as well as a growth in the number of registrations for novel devices by industry participants seeking a competitive advantage, would improve the market value.
The benefit of active vascular closure devices in shortening time to ambulation and haemostasis commanded more than 58 percent of revenue share in 2020. The active vascular closure device employs a variety of ways for direct closure of the artery entry site, including the use of collagen or suture-based materials. Increasing product availability to a bigger population opens up revenue generation opportunities for the segment. Collagen plug devices such as Angio-seal and Mynx, as well as ExoSeal and Starclose devices, are examples of these devices. As a result, more product releases by market participants will benefit segment growth. In 2020, hospitals accounted for more than 59 percent of the vascular closure device market. Patient choice for hospitals will be driven by the widespread use of modern gadgets that provide improved cardiac care. The increasing number of heart stroke admissions, the demand for catheterization and angiography procedures, and the availability of highly skilled specialists all drive the demand for closure devices in these facilities. As a result, patient demand for a well-equipped emergency cardiac department will drive segment revenue in the near future. [caption id="attachment_6528" align="alignnone" width="680"]
The prominent players in the vascular closure devices market Merit Medical Systems, Inc., Abbott Vascular, Biotronik GMBH & CO.KG, COOK Medtronic, Boston Scientific Corporation, C. R. Bard, Inc., ESSENTIAL MEDICAL, Inc., Cardinal Health, W L. Gore & Associates , ST. JUDE MEDICAL, TZ Medical, Inc., Cardival Medical, Inc., Scion BioMedical.
The vascular closure devices market is divided into major regions- North America, Europe, South America, Asia Pacific, and middle east & Africa. North America is the largest regional segment in 2021. Growing penetration of electric cars was the primary factor driving product demand. Furthermore, the growing regulatory support for increasing investments is projected to have a favorable impact on growth.
The country's well-established healthcare infrastructure, the growing incidence of cardiovascular illnesses coupled with an increase in catheterization-related procedures, and the rise in demand for minimally invasive treatments are driving market expansion in the region. North America led the global market for vascular closure devices, followed by Europe. The growing prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increased research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada all contribute to the large share of the North American market.
[caption id="attachment_6529" align="alignnone" width="680"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.